The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways
Health Law Advisor
MARCH 7, 2023
1] The proposed rule also would allow practitioners to prescribe any other Schedule III-V narcotic drug that becomes approved by the Food and Drug Administration (“FDA”) for use in the maintenance or detoxification treatment of OUD, should any such additional drugs be approved. [2] 1301.28.
Let's personalize your content